Search Within

Rajmohan Murali

  1. "Early Drug Development Service"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (8)
  2. Department of Pathology and Laboratory Medicine (8)
  3. Early Drug Development Service (8)
  4. GDMT, Pathology and Laboratory Medicine (8)
  5. GSK Faculty (8)
  6. Gynecology Disease Management Team (8)

More Groups

People
  1. David Hyman (8)
  2. Robert Soslow (6)
  3. David Solit (5)
  4. Sarah Chiang (5)
  5. Achim Jungbluth (4)
  6. Marc Ladanyi (4)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2018 (4)
  4. 2017 (1)
  5. 2015 (1)
Publications
  1. Clinical Cancer Research (3)
  2. American Journal of Surgical Pathology (2)
  3. Journal of Clinical Oncology (1)
  4. Modern Pathology (1)
  5. Nature (1)
Publishers
  1. American Association for Cancer Research (3)
  2. Lippincott Williams & Wilkins (2)
  3. American Society of Clinical Oncology (1)
  4. Nature Publishing Group (1)
  5. Nature Research (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic profiling aids classification of diagnostically challenging uterine mesenchymal tumors with myomelanocytic differentiation
    Journal Article

    Selenica, P.; Conlon, N.; Gonzalez, C.; Frosina, D.; Jungbluth, A. A.; Beets-Tan, R. G. H.; Rao, M. K.; Zhang, Y.; Benayed, R.; Ladanyi, M.; more...
    American Journal of Surgical Pathology (2021)

    Fulltext@MSK | Save
  • Genomic landscape of uterine sarcomas defined through prospective clinical sequencing
    Journal Article

    Hensley, M. L.; Chavan, S. S.; Solit, D. B.; Murali, R.; Soslow, R.; Chiang, S.; Jungbluth, A. A.; Bandlamudi, C.; Srinivasan, P.; Tap, W. D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma
    Journal Article

    Chiang, S.; Cotzia, P.; Hyman, D. M.; Drilon, A.; Tap, W. D.; Zhang, L.; Hechtman, J. F.; Frosina, D.; Jungbluth, A. A.; Murali, R.; more...
    American Journal of Surgical Pathology (2018)

    Fulltext@MSK | Save
  • NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma
    Meeting Abstract

    Chiang, S.; Cotzia, P.; Hyman, D.; Drilon, A.; Hechtman, J.; Jungbluth, A.; Murali, R.; Soslow, R.; Oliva, E.; Benayed, R.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • HER kinase inhibition in patients with HER2-and HER3-mutant cancers
    Journal Article

    Hyman, D. M.; Piha-Paul, S. A.; Won, H.; Rodon, J.; Saura, C.; Shapiro, G. I.; Juric, D.; Quinn, D. I.; Moreno, V.; Doger, B.; more...
    Nature (2018)

    Fulltext@MSK | Save
  • Diverse BRCA1 and BRCA2 reversion mutations in circulating cell-free DNA of therapy-resistant breast or ovarian cancer
    Journal Article

    Weigelt, B.; Comino-MeĢndez, I.; de Bruijn, I.; Tian, L.; Meisel, J. L.; Garcia-Murillas, I.; Fribbens, C.; Cutts, R.; Martelotto, L. G.; Ng, C. K. Y.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Identifying actionable mutations in uterine leiomyosarcoma
    Meeting Abstract

    Soumerai, T.; Hyman, D. M.; Murali, R.; Zehir, A.; O'Cearbhaill, R. E.; Arcila, M. E.; Aghajanian, C.; Soslow, R. A.; Solit, D. B.; Hensley, M. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save